SCHEMBL23861640

SCHEMBL23861640

CC(c1c(O)ccc2ccc(O)cc12)(c1c(O)ccc2ccc(O)cc12)C1CCCCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ ALDH1A1 P00352 5/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ CYP1A2 P05177 3/20 0.35
▸ CYP2D6 P10635 3/20 0.35
▸ CYP2C19 P33261 3/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ TYR P14679 2/20 0.35
▸ NR1I2 O75469 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MIF P14174 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ NFE2L2 Q16236 1/20 0.35
▸ ESR1 P03372 3/20 0.34
▸ GAA P10253 1/20 0.33
▸ MPI P34949 1/20 0.33
▸ HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23861643 0.90 MAPT (0.38) MAPTMEN1KMT2AALDH1A1HSD17B10
SCHEMBL23861642 0.84 ALDH1A1 (0.46) MAPTMEN1KMT2AALDH1A1HSD17B10
SCHEMBL23861591 0.76 CYP2D6 (0.38) MAPTMEN1KMT2AALDH1A1HSD17B10
SCHEMBL2186567 0.76 LMNA (0.50) MEN1KMT2AALDH1A1HSD17B10CYP1A2
SCHEMBL29493119 0.76 LMNA (0.50) MEN1KMT2AALDH1A1HSD17B10CYP1A2
SCHEMBL23861431 0.73 ALDH1A1 (0.41) MAPTMEN1KMT2AALDH1A1HSD17B10
SCHEMBL9618414 0.71 ESR1 (0.47) MAPTMEN1KMT2AALDH1A1HSD17B10
SCHEMBL23861567 0.71 ESR1 (0.41) MAPTMEN1KMT2AALDH1A1HSD17B10
SCHEMBL23861513 0.70 LMNA (0.40) MEN1KMT2AALDH1A1HSD17B10CYP2C9
SCHEMBL5469803 0.69 ESR1 (0.46) KMT2AALDH1A1HSD17B10CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 MAPT 3949/4885MEN1 4292/4885KMT2A 1279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback